Alkahest Company

Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.
Technology: Biotechnology, Health Care, Medical
Industry: End-to-end Drug Development
Headquarters: San Carlos, California, United States
Founded Date: 2014-01-01
Employees Number: 11-50
Funding Status: M&A
Investors Number: 2
Total Funding: 41
Estimated Revenue: Less than $1M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership